DSpace at RU >

Browsing by Author Boots, A.M.H.

Full Text	Issue Date	Title	Author(s)
	2012	Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signaling.	Smeets, R.L.; Fleuren, W.W.M.; He, X.; Vink, P.M.; Wijnands, F., et al
	2012	PD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancer.	Dulos, J.; Carven, G.J.; Boxtel, S.J. van; Evers, S.; Driessen-Engels, L.J., et al
	2012	T cell lessons from the rheumatoid arthritis synovium SCID mouse model: CD3-rich synovium lacks response to CTLA-4Ig but is successfully treated by interleukin-17 neutralization.	Koenders, M.I.; Marijnissen, R.J.; Joosten, L.A.B.; Abdollahi-Roodsaz, S.; Padova, F.E. Di, et al
	2012	Org 214007-0: a novel non-steroidal selective glucocorticoid receptor modulator with full anti-inflammatory properties and improved therapeutic index	Lierop, M.J.C. van; Alkema, W.; Laskewitz, A.J.; Dijkema, R.; van der Maaden, H.M., et al
	2012	Exposure to Candida albicans polarizes a T-cell driven arthritis model towards Th17 responses, resulting in a more destructive arthritis.	Marijnissen, R.J.; Koenders, M.I.; Veerdonk, F.L. van de; Dulos, J.; Netea, M.G., et al
	2011	Mycophenolic acid-mediated suppression of human CD4+ T cells: more than mere guanine nucleotide deprivation	He, X.; Smeets, R.L.; Koenen, H.J.P.M.; Vink, P.M.; Wagenaars, J.A.L., et al
	2011	Increased expression of interleukin-22 by synovial Th17 cells during late stages of murine experimental arthritis is controlled by interleukin-1 and enhances bone degradation	Marijnissen, R.J.; Koenders, M.M.J.F.; Smeets, R.L.; Stappers, M.H.T.; Nickerson-Nutter, C., et al
	2011	CD97 antibody depletes granulocytes in mice under conditions of acute inflammation via a Fc receptor-dependent mechanism.	Veninga, H.; Groot, D.M. de; McCloskey, N.; Owens, B.M.; Dessing, M.C., et al
	2008	Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells.	Koenen, H.J.P.M.; Smeets, R.L.L.; Vink, P.M.; Rijssen, E. van; Boots, A.M.H., et al
	2008	Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice.	Koenders, Mieke; Devesa, I.; Marijnissen, R.J.; Abdollahi-Roodsaz, S.; Boots, A.M.H., et al
	2005	Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1.	Koenders, M.I.; Lubberts, E.; Oppers-Walgreen, B.; Bersselaar, L.A.M. van den; Helsen, M.M.A., et al
	1997	Selection of Self-reactive peptides within human aggrecan by use of HLA-DRB1*0401 peptide binding motif	Boots, A.M.H.; Verheijden, G.F.M.; Schöningh, R.; Staveren, C.J. van; Bos, E., et al